|
1
|
Kim CJ, Reintgen DS and Balch CM: The new
melanoma staging system. Cancer Control. 9:9–15. 2002.
|
|
2
|
Hofmann UB, Westphal JR, Van Muijen GNP
and Ruiter DJ: Matrix metalloproteinases in human melanoma. J
Invest Dermatol. 115:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vihinen P and Kahari VM: Matrix
metalloproteinases in cancer: prognostic markers and therapeutic
targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krasagakis K, Tholke D, Farthmann B,
Eberle J, Mansmann U and Orfanos CE: Elevated plasma levels of
transforming growth factor (TGF)-beta1 and TGF-beta2 in patients
with disseminated malignant melanoma. Br J Cancer. 77:1492–1494.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Krasagakis K, Garbe C, Schrier PI and
Orfanos CE: Paracrine and autocrine regulation of human melanocyte
and melanoma cell growth by transforming growth factor beta in
vitro. Anticancer Res. 14:2565–2571. 1994.PubMed/NCBI
|
|
6
|
Rodeck U, Melber K, Kath R, Menssen HD,
Varello M, Atkinson B and Herlyn M: Constitutive expression of
multiple growth factor genes by melanoma cells but not normal
melanocytes. J Invest Dermatol. 97:20–26. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rodeck U, Bossler A, Graeven U, Fox FE,
Nowell PC, Knabbe C and Kari C: Transforming growth factor beta
production and responsiveness in normal human melanocytes and
melanoma cells. Cancer Res. 54:575–581. 1994.PubMed/NCBI
|
|
8
|
Van Belle P, Rodeck U, Nuamah I, Halpern
AC and Elder DE: Melanoma-associated expression of transforming
growth factor-beta isoforms. Am J Pathol. 148:1887–1894.
1996.PubMed/NCBI
|
|
9
|
Nagashima K, Takagi R and Hoshina H:
Effect of local hyperthermia on metastases in oral squamous cell
carcinoma. Int J Oral Maxillofac Surg. 31:84–89. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sato T, Sawaji Y, Matsui N, Sato H,
Motoharu S, Mori Y and Ito A: Heat shock suppresses membrane type
1-matrix metalloproteinase production and progelatinase A
activation in human fibrosarcoma HT-1080 cells and thereby inhibits
cellular invasion. Biochem Biophys Res Commun. 265:189–193. 1999.
View Article : Google Scholar
|
|
11
|
Nathanson SD, Cerra SD, Hetzel FW, et al:
Changes associated with metastasis in B16-F1 melanoma cells
surviving heat. Archives Sur. 125:216–219. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jordan A, Scholz R, Wust P, Fakhling H and
Felix R: Magnetic fluid hyperthermia (MFH): cancer treatment with
AC magnetic field induced excitation of biocompatible
superparamagnetic nanoparticles. J Magn Magn Mater. 201:413–419.
1999. View Article : Google Scholar
|
|
13
|
Du LH, Zhou JM, Wang XW, Sheng L, Wang GH,
Xie XX, Zhao LY, Liao YP and Tang JT: Effect of local hyperthermia
induced by nanometer magnetic fluid on the rabbit VX2 liver tumor
model. Prog Nat Sci. 19:1705–1712. 2009. View Article : Google Scholar
|
|
14
|
Wilhelm C, Fortin JP and Gazeau F: Tumour
cell toxicity of intracellular hyperthermia mediated by magnetic
nanoparticles. J Nanosci Nanotechnol. 7:2933–2937. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao FP, Cai YY, Zhou J, Xie XX, Ouyang WW,
Zhang YH, Wang XF, Wang XW, Zhao LY and Tang JT: Pullulan acetate
coated magnetite nanoparticles for hyperthermia: preparation,
characterization and in vitro experiments. Nano Res. 3:23–31. 2010.
View Article : Google Scholar
|
|
16
|
Landeghem FK, Maier-Hauff K, Jordan A,
Hoffmann KT, Gneveckow U, Scholz R, Thiesen B, Buck W and Deimling
AV: Post-mortem studies in glioblastoma patients treated with
thermotherapy using magnetic nanoparticles. Biomaterials. 30:52–57.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki M, Shinkai M, Honda H and Kobayashi
T: Anticancer effect and immune induction by hyperthermia of
malignant melanoma using magnetite cationic liposomes. Melanoma
Res. 13:129–135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hilger I, Hergt R and Kaiser WA: Use of
magnetic nanoparticle heating in the treatment of breast cancer.
IEE Proc Nanobiotechnol. 152:33–39. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Johannsen M, Gneveckow U, Eckelt L,
Feussner A, Waldofner N, Scholz R, Deger S, Wust P, Loening SA and
Jordon A: Clinical hyperthermia of prostate cancer using magnetic
nanoparticles: presentation of a new interstitial technique. Int J
Hyperthermia. 21:637–647. 2005. View Article : Google Scholar
|
|
20
|
Jordan A and Maier-Hauff K: Magnetic
nanoparticles for intracranial thermotherapy. J Nanosci
Nanotechnol. 7:4604–4606. 2007.PubMed/NCBI
|
|
21
|
Johannsen M, Thiesen B, Jordan A,
Taymoorian K, Gneveckow U, Waldofner N, Scholz R, Koch M, Lein M,
Jung K and Loening SA: Magnetic fluid hyperthermia (MFH) reduces
prostate cancer growth in the orthotopic Dunning R3327 rat model.
Prostate. 64:283–392. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ito A, Tannka K, Kondo K, Shinkai M, Honda
H, Matsumoto K, Saida T and Kobayashi T: Tumor regression by
combined immunotherapy and hyperthermia using magnetic
nanoparticles in an experimental subcutaneous murine melanoma.
Cancer Sci. 94:308–313. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jordan A, Scholz R, Maier-Hauff K, van
Landeghem FK, Waldoefner N, Teichgraeber U, Pinkemelle J, Brugn H,
Neuman F, Thiesen B, et al: The effect of thermotherapy using
magnetic nanoparticles on rat malignant glioma. J Neurooncol.
78:7–14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie XX, Shao XF, Gao FP, Jin HK, Zhou JM,
Du LH, Zhang YY, Ouyang WW, Wang XW, Zhao LY, et al: Effect of
hyperthermia on invasion ability and TGF-β1 expression of breast
carcinoma MCF-7 cells. Oncol Rep. 25:1573–1579. 2011.PubMed/NCBI
|
|
25
|
Houghton AN and Polsky D: Focus on
melanoma. Cancer Cell. 2:275–278. 2002. View Article : Google Scholar
|
|
26
|
Chiang WC, Wong YK, Lin SC, Chang KW and
Liu CJ: Increase of MMP-13 expression in multi-stage oral
carcinogenesis and epigallocatechin-3-gallate suppress MMP-13
expression. Oral Dis. 12:27–33. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Puente XS, Sanchez LM, Overall CM and
Lopez-Otin C: Human and mouse proteases: a comparative genomic
approach. Nat Rev Genet. 4:544–558. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nelson AR, Fingleton B, Rothenberg ML and
Matrisian LM: Matrix metalloproteinases: biologic activity and
clinical implications. J Clin Oncol. 18:1135–1149. 2000.PubMed/NCBI
|
|
29
|
Ispanovic E and Haas TL: JNK and PI3K
differentially regulate MMP-2 and MT1-MMP mRNA and protein in
response to actin cytoskeleton reorganization in endothelial cells.
Am J Physiol Cell Physiol. 291:579–588. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sawaji Y, Sato T, Seiki M and Ito A: Heat
shock-mediated transient increase in intracellular 3′,5′-cyclic AMP
results in tumor specific suppression of membrane type 1-matrix
metalloproteinase production and progelatinase A activation. Clin
Exp Metastasis. 18:131–138. 2000.PubMed/NCBI
|
|
31
|
Welm AL: TGFbeta primes breast tumor cells
for metastasis. Cell. 133:27–28. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hasegawa Y, Takanashi S, Kanehira Y,
Tsushima T, Imai T and Okumura K: Transforming growth factor-beta1
level correlates with angiogenesis, tumor progression, and
prognosis in patients with nonsmall cell lung carcinoma. Cancer.
91:964–971. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saito H, Tsujitani S, Oka S, Kondo A,
Ikeguchi M, Maeta M and Kaibara N: The expression of transforming
growth factor-beta1 is significantly correlated with the expression
of vascular endothelial growth factor and poor prognosis of
patients with advanced gastric carcinoma. Cancer. 86:1455–1462.
1999. View Article : Google Scholar
|
|
34
|
Tsushima H, Kawata S, Tamura S, Ito N,
Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y and
Matsuzawa Y: High levels of transforming growth factor beta 1 in
patients with colorectal cancer: association with disease
progression. Gastroenterology. 110:375–382. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oft M, Heider KH and Beug H: TGF-beta
signaling is necessary for carcinoma invasiveness and metastasis.
Curr Biol. 8:1243–1252. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yin JJ, Selander K, Chirgwin JM, Dallas M,
Grubbs BG, Wieser R, Massague J, Mundy GR and Guise TA: TGF-beta
signaling blockade inhibits PTHrP secretion by breast cancer cells
and bone metastases development. J Clin Invest. 103:197–206. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cui W, Fowlis DJ, Bryson S, Duffie E,
Ireland H, Balmain A and Akhurst RJ: TGF beta1 inhibits the
formation of benign skin tumors, but enhances progression to
invasive spindle carcinomas in transgenic mice. Cell. 86:531–542.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Padua D, Zhang XHF, Wang QQ, Nadal C,
Gerald WL, Gomis RR and Massague J: TGFbeta primes breast tumors
for lung metastasis seeding through angiopoietin-like 4. Cell.
133:66–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Krasagakis K, Kruger-Krasagakes S, Fimmel
S, Eberle J, Tholke D, von der Ohe M, Mansmann U and Orfanos CE:
Desensitization of melanoma cells to autocrine TGF-beta isoforms. J
Cell Physiol. 178:179–187. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Janji B, Melchior C, Gouon V, Vallar L and
Kieffer N: Autocrine TGF-beta-regulated expression of adhesion
receptors and integrin-linked kinase in HT-144 melanoma cells
correlates with their metastatic phenotype. Int J Cancer.
83:255–262. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Miyoshi E, Nishikawa A, Ihara Y, Saito H,
Uozumi N, Hayashi N, Fusamoto H, Kamada T and Taniguchi N:
Transforming growth factor beta up-regulates expression of the
N-acetyl glucoseminyl transferase V gene in mouse melanoma cells. J
Biol Chem. 270:6216–6220. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Park SS, Li L, Korn TS, Mitra MM and
Niederkorn JY: Effect of transforming growth factor-beta on
plasminogen activator production of cultured human uveal melanoma
cells. Curr Eye Res. 15:755–763. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rodeck U, Nishiyama T and Mauviel A:
Independent regulation of growth and SMAD-mediated transcription by
transforming growth factor beta in human melanoma cells. Cancer
Res. 59:547–550. 1999.PubMed/NCBI
|
|
44
|
Hilger I, Hiergeist R, Hergt R, Winnefeld
K, Schubert H and Kaiser W: Thermal ablation of tumors using
magnetic nanoparticles: an in vivo feasibility study. Invest
Radiol. 37:580–586. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Brusentsova NA, Nikitinb L, Brusentsovac
T, Brusentsava TN, Kuznetsov AA, Beyburtskiy FS, Shumakov LI and
Jurchenko NY: Magnetic fluid hyperthermia of the mouse experimental
tumor. J Magn Magn Mater. 252:378–380. 2002. View Article : Google Scholar
|
